Guangdong Jiaying Pharmaceutical shows significant net incom...
Guangdong Jiaying Pharmaceutical shows significant net income growth despite seeming unimpressive ROE, suggesting efficient management. Full reinvestment of profits further adds to the company's positive outlook despite lower-than-average industry ROE.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000184c394502943e.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment